CompletedPhase 2Phase 3ACTRN12609000558224

Clinical and physiological evaluation of a Chinese herbal medicine for constipation-predominant Irritable Bowel Syndrome (C-IBS Trial).

A double blind randomised placebo controlled clinical trial testing the effectiveness of a Chinese herbal medicine extract formulation for constipation-predominant Irritable Bowel Syndrome.


Sponsor

University of Western Sydney

Enrollment

160 participants

Start Date

Jun 22, 2009

Study Type

Interventional

Conditions

Summary

This research project will test whether Chinese herbal medicine is useful for treating constipation predominant Irritable Bowel Syndrome (C-IBS). C-IBS has multiple symptoms, including abdominal pain, bloating, constipation and changed bowel habits. The Chinese herbal formulation being tested has been designed to address the multiple symptoms of C-IBS.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 65 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests a Chinese herbal medicine for treating constipation-predominant irritable bowel syndrome (IBS) in adults aged 18-65. Participants must have a confirmed IBS diagnosis and recent normal blood tests and colon evaluation.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A seven ingredient plant based Chinese herbal medicine formulation extracted into powder form. Dosage is 5 oral capsules twice per day, morning and evening 20 minutes before food for 8 weeks duration.

A seven ingredient plant based Chinese herbal medicine formulation extracted into powder form. Dosage is 5 oral capsules twice per day, morning and evening 20 minutes before food for 8 weeks duration.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609000558224